Prostate Cancer Awareness: What We Need to Know with Paul Arangua

High mortality rate is likely due to an underutilization of screening in men. You know, back in 2012, the US Preventive Services Task Force had analyzed a couple of multicenter studies that demonstrated that there really wasn't a strong benefit to doing screening amongst men who have prostate cancer., and they had initiated a warning against doing screening for, for using PSA. And one of the problems of that, one of the studies they looked at, which was the PLCO study, was that only 7% of the population had a family history of prostate cancer. So the generalizability of those individuals who were taking part in the study weren't exactly representative of what we see in the United States.